You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

EVENTS

Kedrion supports the 2020 European Hemophilia Consortium Conference

The company renews its commitment alongside the EHC, which continues to support the PARTNERS project

read more 

CORPORATE

KEDPLASMA GmbH changes its name to Kedrion Biopharma GmbH

Further step towards an even stronger focus on patients in Europe

read more 
  1. EVENTS - 28-04-2020

    Kedrion Biopharma supports the 2020 Primary Immunodeficiency Week

    The company stands alongside the global PI community

    read more 
  2. EVENTS - 17-04-2020

    World Hemophilia Day: socially distant but still united with patients

    Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder

    read more 
  3. EVENTS - 16-04-2020

    Kedrion supports live streaming of medical debate on the use of convalescent plasma to treat Covid-19

    Online roundtable “The Gift of the Cured versus the Pandemic” on air at DonatoriH24 on April 16

    read more 

Pages

For more information please contact: pressoffice@kedrion.com